Alembic gains final USFDA approval for Albendazole Tablets USP, 200 mg EP News Bureau Sep 5, 2024 Albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms…
Dr Reddy’s launches of AlbendazoleTablets, USP in the US market EP News Bureau Apr 29, 2021 Albendazole is an anthelmintic drug to treat parenchymal neurocysticercosis and cystic hydatid disease of the liver, lung, and…
